Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Short Interest Update

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the target of a significant decline in short interest in June. As of June 15th, there was short interest totalling 19,400 shares, a decline of 33.1% from the May 31st total of 29,000 shares. Based on an average daily trading volume, of 15,800 shares, the days-to-cover ratio is presently 1.2 days.

Cardio Diagnostics Stock Up 21.6 %

Shares of CDIOW traded up $0.01 during mid-day trading on Friday, hitting $0.04. 1,430 shares of the company were exchanged, compared to its average volume of 19,042. Cardio Diagnostics has a 1-year low of $0.03 and a 1-year high of $0.28. The company has a 50 day moving average of $0.06 and a 200-day moving average of $0.11.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.